Replies to post #152047 on Innovation Pharmaceuticals Inc (IPIX)

[cybermich]

loanranger..

so you are saying that CTIX's success would have hinged on being accepted into the RUSSELL 2000.. and that alone would have saved CTIX from being shorted to heck and back?

Maybe "myopic" is too strong of a word.. but uplisting in the midst of a short attack (and then with hindsight seeing what a frivolous lawsuit and a couple hit pieces can do).. being on a higher exchange does not insulate a company from being manipulated..

some "forced buying" from the RUSSELL 2000 is not a magic bullet.

I could give you a couple very specific examples of companies who have extensive institutional ownership.. AND in the indexes.. AND both uplisted in the past couple years.. AND both have been
brought down hard by the shorts..

of course each company brings its own fundamentals and story to the table.. but one thing seems to be
constant.. it takes some special "material" news.. usually in the form of a good partnership (with money in the bank) to hold any type of significant gains.. and EVEN THAT often times does not keep the shorts in check.

p.s. again in hindsight.. CTIX probably would have been attacked whether or not they had uplisted.. and I applaud the CEO for at least admitting his mistake (telegraphing his intentions).. but imo there should be no confusion about who is perpetuating the harm.

[F1ash]

And just when I was beginning to think I had a pretty good handle on the situation...

" BUT their reverse split and uplisting (in Oct) didn't provide the full kick that it normally provides because it occurred after the opportunity to enter the Russell 2000 had passed (it changes every year...based on market cap on the last Friday in May...and they probably [not calculated yet]**** fell short this year based on the drop in share price and its market cap impact.

So, if I read this correctly, not only is up listing important, the timing of it may actually be more important?

Where is the anger at their CEO for up listing at the wrong time? If I read correctly he is well connected in the financial world. How did he make such a critical error. I didn't look at the exact price but it was somewhere around $9 a share on Nasdaq listing day. October 28th 2015. That other company has not suffered a single trial failure (failure is a virtual impossibility with their current trial design imho).

Their share price sits at ~$4 right now. Their short interest is over 10% and Cellceutix's is at ~1%.

If Cellceutix up-listed but missed the date like that company would the results be similar? Did that other CEO bungle their up-listing? Should one be buying that stock right now? Aren't they going to be included on the Russell 3000 very soon. As long as there is no news from the company between now and then it seems share price increase should be a virtual lock then?

[believer20]

All known. Ty for laying it out.. We were all waiting for the uplist before the Russell deadline. I guess we'll have to wait until asco 2020? Ridiculous